This is a news story, published by Ars Technica, that relates primarily to FDA news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Ars Technica, you can click here:
more news from Ars TechnicaOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Semaglutide overdoses. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest semaglutide products news, semaglutide news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
semaglutide drugsArs Technica
•83% Informative
The FDA says people are overdosing on off-brand injections of semaglutide.
Compounding pharmacies can legally make their own versions of FDA -approved drugs.
The FDA has approved two injectable versions of the weight-loss and diabetes drug.
The agency urges patients and prescribers to only use compounded versions when absolutely necessary.
VR Score
82
Informative language
82
Neutral language
47
Article tone
formal
Language
English
Language complexity
75
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
2
Affiliate links
no affiliate links